Georges Nembot

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

Antoine Chéret, Charline Bacchus-Souffan, Véronique Avettand-Fènoël et al. · Journal of Antimicrobial Chemotherapy · 2015 · 103 citations

Life Sciences, Cell Biology, Immunology +16

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

Antoine Chéret, Georges Nembot, Adeline Mélard et al. · The Lancet Infectious Diseases · 2015 · 72 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection

Charline Bacchus, Antoine Chéret, Véronique Avettand-Fènoël et al. · PLoS ONE · 2013 · 69 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Radojka M. Savić, Aurélie Barrail‐Tran, Xavier Duval et al. · Clinical Pharmacology & Therapeutics · 2012 · 49 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

Pierre Frange, Lambert Assoumou, Diane Descamps et al. · Journal of Antimicrobial Chemotherapy · 2015 · 44 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17